Skip to content

Clinical observation of pharyngeal function by Ciprofol in Outpatients undergoing gastroscopy

Clinical observation on the the incidence and severity of swallowing impairment induced by Ciprofol in Outpatients undergoing gastroscopy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054446
Enrollment
Unknown
Registered
2021-12-17
Start date
2021-12-20
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control group:Propofol

Sponsors

Affiliated Hospital of Chengdu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years, both male and female; 2. Body mass index (BMI): >=18 and <= 30kg/m2; 3. Patients undergoing painless gastroscopy; 4. American Anesthesiologist Classification (ASA) I-II; 5. Be able to understand the research process and methods, and voluntarily participate in this research.

Exclusion criteria

Exclusion criteria: 1. Those with contraindications to general anesthesia or those who have had a history of anesthesia accident in the past; 2. Known or suspected allergies or contraindications to propofol injection, cyclopofol injection excipients, benzodiazepines, opioids, muscle relaxants, etc.; 3. Combined with craniocerebral loss, intracranial hypertension, stroke, unstable angina, myocardial infarction; 4. Respiratory insufficiency, obstructive pulmonary disease, difficult airway, or tracheal intubation is judged to be difficult (modified Markov score is grade III or grade IV); 5. Uncontrolled diabetes or high blood pressure; 6. Insufficient fasting time (fasting 30 severely obese; 10. Severe neurological disease, unable to cooperate with the examination (such as acute stroke, convulsion, epilepsy not effectively controlled); 11. Those with a history of oropharyngeal surgery or with swallowing dysfunction before surgery; 12. Those who have participated in any drug clinical trials within 1 month before screening; 13. Those with allergies to sedative/anesthetic drugs and other serious anesthesia risks; 14. Patients with nasal polyps, nasal bleeding tendency, nasal trauma, nasal deformity, nasal inflammation, etc.; patients with a history of mandibular joint dislocation or mandibular injury.

Design outcomes

Primary

MeasureTime frame
Positive rate of pharyngeal refle;

Secondary

MeasureTime frame
Glottis motion;Exposure of tracheal cartilage retroglottic;The Dysphagia Severity Score;The Penetration and Aspiration Scale;

Countries

China

Contacts

Public ContactWang Xiong

Affiliated Hospital of Chengdu University

995620427@qq.com+86 13679006866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026